ATE508361T1 - Absolute quantifizierung von proteinen und modifizierten formen davon mittels mehrstufiger massenspektrometrie - Google Patents

Absolute quantifizierung von proteinen und modifizierten formen davon mittels mehrstufiger massenspektrometrie

Info

Publication number
ATE508361T1
ATE508361T1 AT02757101T AT02757101T ATE508361T1 AT E508361 T1 ATE508361 T1 AT E508361T1 AT 02757101 T AT02757101 T AT 02757101T AT 02757101 T AT02757101 T AT 02757101T AT E508361 T1 ATE508361 T1 AT E508361T1
Authority
AT
Austria
Prior art keywords
proteins
amino acid
mass spectrometry
modified forms
absolute quantification
Prior art date
Application number
AT02757101T
Other languages
English (en)
Inventor
Steven P Gygi
Scott Gerber
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23210708&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE508361(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Harvard College filed Critical Harvard College
Application granted granted Critical
Publication of ATE508361T1 publication Critical patent/ATE508361T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6818—Sequencing of polypeptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00—Labels used in chemical analysis of biological material
    • G01N2458/15—Non-radioactive isotope labels, e.g. for detection by mass spectrometry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AT02757101T 2001-08-14 2002-08-14 Absolute quantifizierung von proteinen und modifizierten formen davon mittels mehrstufiger massenspektrometrie ATE508361T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31227901P 2001-08-14 2001-08-14
PCT/US2002/025778 WO2003016861A2 (en) 2001-08-14 2002-08-14 Absolute quantification of proteins and modified forms thereof by multistage mass spectrometry

Publications (1)

Publication Number Publication Date
ATE508361T1 true ATE508361T1 (de) 2011-05-15

Family

ID=23210708

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02757101T ATE508361T1 (de) 2001-08-14 2002-08-14 Absolute quantifizierung von proteinen und modifizierten formen davon mittels mehrstufiger massenspektrometrie

Country Status (6)

Country Link
EP (1) EP1472539B1 (de)
AT (1) ATE508361T1 (de)
AU (1) AU2002323139A1 (de)
CA (1) CA2457695A1 (de)
DE (1) DE60239962D1 (de)
WO (1) WO2003016861A2 (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7300753B2 (en) * 1998-09-04 2007-11-27 John Rush Immunoaffinity isolation of modified peptides from complex mixtures
US7632686B2 (en) 2002-10-03 2009-12-15 Anderson Forschung Group High sensitivity quantitation of peptides by mass spectrometry
EP2186879B1 (de) 2002-10-03 2016-11-23 Norman Leigh Anderson Hochempfindliche Quantifizierung von Peptiden mittels Massenspektrometrie
EP1634083A2 (de) * 2003-06-17 2006-03-15 VIB vzw Peptide-zusammenstellungen und deren anwendungen
EP2208992A1 (de) 2003-11-21 2010-07-21 Eisai R&D Management Co., Ltd. Quantifizierungsverfahren mit Verwendung eines isotopenmarkierten inneren Standards, Analysesystem zur Durchführung des Quantifizierungsverfahrens sowie Programm zum Abbau davon
US20060154318A1 (en) * 2004-06-09 2006-07-13 Anderson Norman L Stable isotope labeled polypeptide standards for protein quantitation
GB0414233D0 (en) * 2004-06-25 2004-07-28 Bioinvent Int Ab Analysis method
US7973134B2 (en) 2004-07-07 2011-07-05 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways
EP1619503A1 (de) * 2004-07-15 2006-01-25 BioVisioN AG Verwendung von Standards zur Kontrolle von Veränderungen in Pepitd- und Proteinproben
US7935790B2 (en) 2004-10-04 2011-05-03 Cell Singaling Technology, Inc. Reagents for the detection of protein phosphorylation in T-cell receptor signaling pathways
US7807789B2 (en) 2004-12-21 2010-10-05 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in EGFR-signaling pathways
WO2006068640A1 (en) * 2004-12-21 2006-06-29 Cell Signaling Technology, Inc. Protein phosphorylation in egfr-signaling pathways
DE602005004902T2 (de) * 2005-06-02 2008-10-16 Entelechon Gmbh Künstliches Protein, Verfahren für absolute Quantifizierung der Proteine und seine Benutzung
ES2452025T3 (es) * 2005-06-30 2014-03-31 Biocrates Life Sciences Ag Aparato de análisis de un perfil de metabolitos
WO2007027867A2 (en) 2005-08-31 2007-03-08 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
EP1934867A2 (de) 2005-08-31 2008-06-25 Cell Signaling Technology, Inc. Reagentien zum nachweis der proteinphosphorylierung in leukämie-signalwegen
PL1931998T3 (pl) 2005-09-15 2010-11-30 Alk Abello As Sposób ilościowego oznaczania alergenów
WO2007084631A2 (en) 2006-01-20 2007-07-26 Cell Signaling Technology, Inc. Translocation and mutant ros kinase in human non-small cell lung carcinoma
US20120208824A1 (en) 2006-01-20 2012-08-16 Cell Signaling Technology, Inc. ROS Kinase in Lung Cancer
PT2450437T (pt) 2006-04-14 2017-08-25 Cell Signaling Technology Inc Defeitos de genes e cinase alk mutante em tumores sólidos humanos
WO2008009004A2 (en) * 2006-07-13 2008-01-17 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in signaling pathways
US20100151483A1 (en) * 2006-07-13 2010-06-17 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in signaling pathways
US7939636B2 (en) 2006-08-11 2011-05-10 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in c-Src signaling pathways
US20090081659A1 (en) 2007-03-07 2009-03-26 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
GB0704764D0 (en) 2007-03-12 2007-04-18 Electrophoretics Ltd Isobarically labelled reagents and methods of their use
US20090068684A1 (en) 2007-03-26 2009-03-12 Cell Signaling Technology, Inc. Serine and threoninephosphorylation sites
EP1983003A3 (de) 2007-04-19 2009-03-11 Peter Hornbeck Tyrosinphosphorylationsstellen und spezifische Antikörper
US7977462B2 (en) 2007-04-19 2011-07-12 Cell Signaling Technology, Inc. Tyrosine phosphorylation sites
EP2145902A3 (de) 2007-04-19 2010-09-29 Peter Hornbeck Tyrosinphosphorylations-Stellen und spezifische Antikörper
US20090053831A1 (en) 2007-05-01 2009-02-26 Cell Signaling Technology, Inc. Tyrosine phosphorylation sites
JP5769968B2 (ja) 2007-10-18 2015-08-26 セル・シグナリング・テクノロジー・インコーポレイテツド ヒト非小細胞肺癌における転座および変異ｒｏｓキナーゼ
US20090203043A1 (en) 2007-11-21 2009-08-13 Peter Hornbeck Protein phosphorylation by basophilic serine/threonine kinases in insulin signaling pathways
WO2009117785A1 (en) * 2008-03-28 2009-10-01 Newsouth Innovations Pty Limited Method of hla tissue typing
EP3266795A1 (de) 2009-02-12 2018-01-10 Cell Signaling Technology, Inc. Verfahren zum detektieren von fig-ros-fusionspolynukleotid
EP2545384B1 (de) 2010-03-12 2017-12-13 JPT Peptide Technologies GmbH Verfahren zur bestimmung der konzentration eines peptids
DE112011102286B4 (de) 2010-07-07 2018-11-15 Thermo Fisher Scientific Gmbh Massenspektrometrische Quantifizierung von Analyten unter Verwendung eines Universalreporters
US20120101108A1 (en) 2010-08-06 2012-04-26 Cell Signaling Technology, Inc. Anaplastic Lymphoma Kinase In Kidney Cancer
JP6211931B2 (ja) 2011-03-09 2017-10-11 セル・シグナリング・テクノロジー・インコーポレイテツド モノクローナル抗体を作製するための方法および試薬
EP2508537A1 (de) * 2011-04-04 2012-10-10 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Quantitativer Standard für die Massenspektrometrie von Proteinen
GB201110371D0 (en) 2011-06-17 2011-08-03 Proteome Sciences R & D Gmbh & Co Kg Materials and methods for determining sensitivity potential of compounds
PL2838998T3 (pl) 2012-04-18 2018-04-30 Cell Signaling Technology, Inc. EGFR i ROS1 w nowotworze
WO2013173756A1 (en) * 2012-05-18 2013-11-21 University Of North Dakota A method for quantifying proteins and isoforms thereof
DK2859343T3 (da) 2012-06-06 2019-12-09 Attoquant Diagnostics Gmbh Fremgangsmåde til måling af peptidiske nedbrydningsprodukter af en proteolytisk kaskade i blodprøver
US10155987B2 (en) 2012-06-12 2018-12-18 Dana-Farber Cancer Institute, Inc. Methods of predicting resistance to JAK inhibitor therapy
CN103134881A (zh) * 2013-02-01 2013-06-05 浙江省疾病预防控制中心 一种牛α-乳白蛋白定量检测试剂盒及其应用
EP2961766B1 (de) 2013-03-01 2019-04-10 Boehringer Ingelheim Vetmedica, Inc. Quantifizierung von impfstoffzusammensetzungen
EP2793026A1 (de) 2013-04-18 2014-10-22 Centre National de la Recherche Scientifique (CNRS) Neues Verfahren zur Überwachung von Krebs und/oder der Entzündungsreaktion auf Grundlage der RelB-Phosphorylierung
CN103293317B (zh) * 2013-04-28 2015-08-05 浙江省疾病预防控制中心 一种牛乳β-乳球蛋白定量检测试剂盒及其应用
GB201310203D0 (en) 2013-06-07 2013-07-24 Electrophoretics Ltd Materials and methods relating to Alzheimer's disease
CN105143872B (zh) 2013-06-07 2019-03-01 皮尔斯生物科技有限公司 通过质谱分析用复用内标物对蛋白质和蛋白质修饰的绝对定量
GB201314485D0 (en) 2013-08-13 2013-09-25 Electrophoretics Ltd Materials and methods relating to pancreatic cancer
CN103439399B (zh) * 2013-09-12 2019-05-14 中国计量科学研究院 一种甲胎蛋白标准物质定值的方法
EP2863228A1 (de) 2013-10-18 2015-04-22 Attoquant Diagnostics GmbH Verfahren zur Diagnose von primärem Hyperaldosteronismus
GB201320061D0 (en) 2013-11-13 2013-12-25 Electrophoretics Ltd Materials nad methods for diagnosis and prognosis of liver cancer
US12019081B2 (en) 2020-11-06 2024-06-25 University Of Kentucky Research Foundation Method for detection and quantification of CLN3 protein

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
US6670194B1 (en) * 1998-08-25 2003-12-30 University Of Washington Rapid quantitative analysis of proteins or protein function in complex mixtures
US20020123055A1 (en) 2000-08-25 2002-09-05 Estell David A. Mass spectrometric analysis of biopolymers
US6426206B1 (en) 2000-11-13 2002-07-30 Pe Corporation (Ny) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2002084250A2 (en) * 2001-04-17 2002-10-24 Femtolink Biotechnologies Llc Methods for mass spectrometry detection and quantification of specific target proteins in complex biological samples

Also Published As

Publication number Publication date
AU2002323139A1 (en) 2003-03-03
CA2457695A1 (en) 2003-02-27
DE60239962D1 (de) 2011-06-16
WO2003016861A2 (en) 2003-02-27
EP1472539B1 (de) 2011-05-04
EP1472539A2 (de) 2004-11-03
WO2003016861A3 (en) 2004-08-19
EP1472539A4 (de) 2006-03-29

Similar Documents

Publication Publication Date Title
ATE508361T1 (de) Absolute quantifizierung von proteinen und modifizierten formen davon mittels mehrstufiger massenspektrometrie
Tsai et al. Mass spectrometry-based strategies for protein disulfide bond identification
Staes et al. Improved recovery of proteome‐informative, protein N‐terminal peptides by combined fractional diagonal chromatography (COFRADIC)
Jiang et al. Quantitative analysis of severe acute respiratory syndrome (SARS)-associated coronavirus-infected cells using proteomic approaches: implications for cellular responses to virus infection
DE60124265D1 (de) Durch affinität ausgewählte unterschriftspeptide zur identifizierung und quantifizierung von proteinen
Cheng et al. Using the Doubly Charged Selected Ion Coupled with MS/MS Fragments Monitoring (DCSI‐MS/MS) Mode for the Identification of Gelatin Species
DE60135504D1 (de) Isotop-kodierte ionisierung-förderende reagenzien zur hochdurchsatz protein identifikation und quantifikation mit massenspectrometrie
Chiappetta et al. Quantitative identification of protein nitration sites
Cahill et al. Analysis of relative isotopologue abundances for quantitative profiling of complex protein mixtures labelled with the acrylamide/D3‐acrylamide alkylation tag system
Goyder et al. Strategies in mass spectrometry for the assignment of Cys-Cys disulfide connectivities in proteins
Borch et al. Mass spectrometric analysis of protein interactions
Dai et al. Enrichment and identification of cysteine-containing peptides from tryptic digests of performic oxidized proteins by strong cation exchange LC and MALDI-TOF/TOF MS
Pan et al. N-terminal labeling of peptides by trypsin-catalyzed ligation for quantitative proteomics.
Rietschel et al. Membrane protein analysis using an improved peptic in‐solution digestion protocol
US20040096876A1 (en) Quantitative analysis via isotopically differentiated derivatization
Mendoza‐Porras et al. Cytokines in the grass, a lesson learnt: Measuring cytokines in plasma using multiple reaction monitoring mass spectrometry
Liao et al. Strategy combining separation of isotope-labeled unfolded proteins and matrix-assisted laser desorption/ionization mass spectrometry analysis enables quantification of a wide range of serum proteins
Wei et al. High-throughput absolute quantification of proteins using an improved two-dimensional reversed-phase separation and quantification concatemer (QconCAT) approach
Lengqvist et al. Stable isotope labeling methods in protein profiling
JP2008503738A (ja) 分析方法
Julka et al. Detection of C-terminal peptide of proteins using isotope coding strategies
TWI694253B (zh) 具有胺基團的目標分子的絕對定量方法
Goodlett et al. Stable isotopic labeling and mass spectrometry as a means to determine differences in protein expression
Ebhardt et al. Enzymatic generation of peptides flanked by basic amino acids to obtain MS/MS spectra with 2× sequence coverage
Syal et al. Modifications in trypsin digestion protocol for increasing the efficiency and coverage

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties